期刊文献+
共找到10篇文章
< 1 >
每页显示 20 50 100
MBP在小鼠肝癌H22荷瘤模型中的抗肿瘤作用 被引量:1
1
作者 门颖丽 康巧珍 +6 位作者 王小龙 杜明宣 黄夏冰 张亚萌 汲振余 王婷 刘鑫 《郑州大学学报(医学版)》 CAS 北大核心 2016年第3期313-316,共4页
目的:探讨大肠杆菌麦芽糖结合蛋白(MBP)在小鼠肝癌H22荷瘤模型中的抗肿瘤作用及可能机制。方法:将12只6~8周龄的BALB/c小鼠皮下注射2×10^6个H22细胞,建立荷瘤模型,荷瘤后第2天将小鼠分为PBS组和MBP组,每组6只,并通过皮下瘤旁... 目的:探讨大肠杆菌麦芽糖结合蛋白(MBP)在小鼠肝癌H22荷瘤模型中的抗肿瘤作用及可能机制。方法:将12只6~8周龄的BALB/c小鼠皮下注射2×10^6个H22细胞,建立荷瘤模型,荷瘤后第2天将小鼠分为PBS组和MBP组,每组6只,并通过皮下瘤旁注射给药的方式进行干预,期间监测肿瘤体积和小鼠体重变化,测量肿瘤和各脏器质量,ELISA法检测脾细胞分泌IL-12和IFN-γ的水平,Real-time PCR检测肿瘤组织中IFN-γ和IL-17A mRNA的相对表达量。结果:MBP能抑制肿瘤的生长(P〈0.05)。与PBS组相比,MBP组小鼠脾细胞中IL-12、IFN-γ分泌量上升,肿瘤组织中IFN-γmRNA的表达量上升,IL-17A mRNA的表达量下降(P〈0.05)。结论:MBP能够有效抑制肝癌H22肿瘤生长,其作用可能是通过激活Th1型免疫反应和抑制Th17型免疫反应。 展开更多
关键词 麦芽糖结合蛋白 小鼠肝癌H22荷瘤模型 TH1 TH17
下载PDF
β-catenin在小鼠化学肝癌形成过程中的动态变化 被引量:4
2
作者 唐超莉 匡志鹏 杨帆 《现代肿瘤医学》 CAS 2013年第6期1204-1208,共5页
目的:检测β-catenin在化学诱导C57BL/6J小鼠肝癌过程中各时期的动态变化。方法:化学法[二乙基亚硝胺(diethylnirtosamine,DEN)/四氯化碳(carbon tetrachloride,CCl4)/乙醇]诱发50只C57BL/6J雄性小鼠肝癌,对照组为45只正常C57BL/6J雄性... 目的:检测β-catenin在化学诱导C57BL/6J小鼠肝癌过程中各时期的动态变化。方法:化学法[二乙基亚硝胺(diethylnirtosamine,DEN)/四氯化碳(carbon tetrachloride,CCl4)/乙醇]诱发50只C57BL/6J雄性小鼠肝癌,对照组为45只正常C57BL/6J雄性小鼠。观察小鼠成瘤情况和生长状态,对每2周定期处死小鼠获得的组织标本分别进行病理学切片观察,并采用荧光实时定量PCR、免疫组织化学法和蛋白质印迹法分别检测β-catenin mRNA和蛋白的表达情况。结果:化学诱导20周后,成功诱发小鼠肝癌。荧光实时定量PCR第4周起小鼠肝癌组织中β-catenin的表达高于正常对照组,差异有统计学意义(P<0.05)。随着诱癌时间的增加,β-catenin的表达量呈上升趋势,第18和20周时诱癌组β-catenin的表达明显高于前一诱癌组(P<0.05)。蛋白印记法及免疫组化检测发现诱癌组第4周起至第14周细胞核内β-catenin有表达,细胞质内的表达也较正常对照组多,细胞膜表达减弱,这期间诱癌组间细胞核和细胞浆内β-catenin表达无明显差异。第16周可发现细胞浆内的β-catenin蛋白表达较之前时间组降低,第20周降至最低。而第18周和第20周细胞核的β-catenin蛋白表达明显多于前面时间段,第20周最多。细胞膜无表达。结论:随着肝癌演变,细胞浆内的β-catenin蛋白有可能向细胞核内移位,致使细胞核内β-catenin蛋白更进一步累积,激活一系列靶基因,导致肝癌形成。β-catenin蛋白在细胞膜、细胞浆和细胞核中分布在正常肝脏组织、肝硬化、肝癌这一过程中均不相同,表明β-catenin与肝癌的发生发展有密切关系。 展开更多
关键词 肝癌 小鼠肝癌模型 Β-CATENIN 肝癌干细胞
下载PDF
IL-21基因治疗小鼠H22细胞皮下移植肝癌模型的效果评价 被引量:2
3
作者 王丽娜 郑洁 +4 位作者 鞠吉雨 牟东珍 孙萍 邸大琳 苗乃法 《现代免疫学》 CAS CSCD 北大核心 2010年第2期115-118,共4页
用已构建的mIL-21/pcDNA3.1重组质粒对H22细胞建立的小鼠肝癌模型进行基因治疗,观察IL-21对小鼠体内抗肿瘤免疫应答的影响及对小鼠生存的影响。采用BALB/c小鼠左腋皮下注射腹水型肝癌细胞株H22细胞建立小鼠移植肝癌模型,给荷瘤小鼠瘤体... 用已构建的mIL-21/pcDNA3.1重组质粒对H22细胞建立的小鼠肝癌模型进行基因治疗,观察IL-21对小鼠体内抗肿瘤免疫应答的影响及对小鼠生存的影响。采用BALB/c小鼠左腋皮下注射腹水型肝癌细胞株H22细胞建立小鼠移植肝癌模型,给荷瘤小鼠瘤体内注射mIL-21/pcDNA3.1进行基因治疗,MTT比色法检测IL-21对荷瘤小鼠T细胞增殖水平及NK细胞杀伤活性的影响,观察治疗后荷瘤小鼠生存情况及肿瘤生长情况的改变。病理检测结果显示,成功建立了小鼠移植型肝癌模型,MTT比色法显示基因治疗后小鼠T细胞增殖水平及NK细胞杀伤活性显著升高,荷瘤小鼠肿瘤生长速度减慢,生存期显著延长。IL-21基因治疗肝癌荷瘤小鼠可显著提高荷瘤小鼠体内抗肿瘤免疫应答水平,抑制肿瘤生长,延长荷瘤小鼠生存期。 展开更多
关键词 IL-21 基因治疗 H22细胞 小鼠肝癌模型
原文传递
莪术提取物榄香烯对肝癌H22荷瘤小鼠的抑瘤作用 被引量:18
4
作者 李慧乐 莫传伟 +3 位作者 赵春辉 刘潇雅 王吉利 卢俊 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第11期1345-1348,共4页
目的研究莪术提取物榄香烯对肝癌H22荷瘤小鼠的抑瘤作用。方法选取昆明小鼠,用H22肝癌细胞悬液0.1 mL右腋下接种建立肝癌荷瘤小鼠模型。剩余17只作为正常组(右腋下注射0.9%Na Cl 0.1 mL)。将造模成功的小鼠按照体重随机分为3组,各17只:... 目的研究莪术提取物榄香烯对肝癌H22荷瘤小鼠的抑瘤作用。方法选取昆明小鼠,用H22肝癌细胞悬液0.1 mL右腋下接种建立肝癌荷瘤小鼠模型。剩余17只作为正常组(右腋下注射0.9%Na Cl 0.1 mL)。将造模成功的小鼠按照体重随机分为3组,各17只:模型组、对照组、实验组。模型组和正常组腹腔内注射0.9%Na Cl 0.2 mL;对照组腹腔内注射氟尿嘧啶注射液20mg·kg^(-1);实验组腹腔内注射榄香烯注射液100 mg·kg^(-1),均qd,均连续给药10d。用称重法测定小鼠肿瘤重量并计算抑瘤率、胸腺指数和脾指数;用免疫组化法检测肿瘤组织生存素(Survivin)、半胱氨酸天冬氨酸蛋白酶-3(Caspase-3)蛋白表达水平;用逆转录-聚合酶链反应检测肿瘤组织Survivin mRNA、Caspase-3 mRNA表达水平。结果给药后,模型组、对照组、实验组肿瘤重量分别为(3.09±0.43),(1.02±0.12),(1.24±0.15)g,对照组和实验组与模型组比较,差异均有统计学意义(均P<0.05)。对照组、实验组的抑瘤率分别为66.99%和59.87%,组间比较差异有统计学意义(P<0.05)。正常组、模型组、对照组、实验组肿瘤组织Survivin蛋白表达水平分别为(3.67±0.47)×10~4,(31.84.±2.74)×10~4,(23.84±2.75)×10~4,(27.85±3.05)×10~4,模型组与正常组比较,差异有统计学意义(P<0.05);对照组和实验组与模型组比较,差异均有统计学意义(均P<0.05)。与模型组比较,对照组、实验组的肿瘤组织Survivin mRNA表达水平较低,而Caspase-3蛋白、Caspase-3 mRNA表达水平较高,差异均有统计学意义(均P<0.05)。结论莪术提取物榄香烯能通过调节Survivin、Caspase-3表达来抑制肝癌H22荷瘤小鼠肿瘤生长。 展开更多
关键词 莪术提取物榄香烯 小鼠肝癌模型 抑瘤作用 氟尿嘧啶注射液
原文传递
氯化镉抗肿瘤作用的体内实验研究 被引量:5
5
作者 杜海英 金明华 +3 位作者 刘颖 刘晓梅 王雯 孙志伟 《现代预防医学》 CAS 北大核心 2008年第19期3763-3765,共3页
[目的]研究氯化镉(CdCl2)抗肿瘤作用及对体内正常组织的影响。[方法]体内建立人肝癌裸小鼠移植瘤模型,阴性对照组给予生理盐水,阳性对照组给予5-Fu25mg/kg,实验组分别给予CdCl20.5、1.0、2.0mg/kg,锌保护组预先给Zn2+10mg/kg,24h后给予C... [目的]研究氯化镉(CdCl2)抗肿瘤作用及对体内正常组织的影响。[方法]体内建立人肝癌裸小鼠移植瘤模型,阴性对照组给予生理盐水,阳性对照组给予5-Fu25mg/kg,实验组分别给予CdCl20.5、1.0、2.0mg/kg,锌保护组预先给Zn2+10mg/kg,24h后给予CdCl22.0mg/kg。观察CdCl2的抑瘤效应及对正常组织的影响。[结果]Cd-Cl2在体内可显著抑制SMMC-7721的增长,同时可引起外周血白细胞数减少,肝指数降低。[结论]CdCl2具有显著的抑瘤效应,锌作为保护剂可能通过诱导金属硫蛋白的表达拮抗镉的部分毒副作用。 展开更多
关键词 氯化镉 肝癌小鼠移植瘤模型 金属硫蛋白
下载PDF
肝癌小鼠外周血及脾脏T淋巴细胞亚群的变化及其意义 被引量:10
6
作者 徐自慧 王雅蕾 +9 位作者 万亮琴 何芳 陈紫微 王雪 宋晨晨 谭琰 王旭 董瑞娟 葛东宇 华茜 《现代生物医学进展》 CAS 2019年第8期1406-1409,共4页
目的:观察小鼠原位肝癌模型外周血以及脾脏T淋巴细胞亚群与正常小鼠之间的差异变化,探讨其差异变化的意义。方法:在正常KM小鼠肝脏种植H22细胞,建立小鼠原位模型。采用流式细胞术,以健康正常小鼠为对照,检测肝癌小鼠外周血以及脾脏T淋... 目的:观察小鼠原位肝癌模型外周血以及脾脏T淋巴细胞亚群与正常小鼠之间的差异变化,探讨其差异变化的意义。方法:在正常KM小鼠肝脏种植H22细胞,建立小鼠原位模型。采用流式细胞术,以健康正常小鼠为对照,检测肝癌小鼠外周血以及脾脏T淋巴细胞亚群的变化。结果:与健康正常小鼠相比,肝癌小鼠外周血CD4^+T淋巴细胞、CD4^+/CD8^+比例有显著性降低,CD8^+T淋巴细胞显著性升高;脾脏CD3^+、CD4^+T淋巴细胞有显著性降低。结论:小鼠原位肝癌模型外周血以及脾脏T淋巴细胞亚群发生异常,免疫系统紊乱,可以反映小鼠肝癌的发生、发展。 展开更多
关键词 小鼠原位肝癌模型 T淋巴细胞亚群 流式细胞术
原文传递
Screening difFerentially expressed genes in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis 被引量:2
7
作者 Xiao-NanCui Jian-WuTang +3 位作者 LiHOU BoSong LiLi Ji-WeiLiu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第12期1837-1842,共6页
AIM: To screen genes differentially expressed in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis.METHODS: A subtracted cDNA library of mouse hepatocarcinoma cell line with high pote... AIM: To screen genes differentially expressed in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis.METHODS: A subtracted cDNA library of mouse hepatocarcinoma cell line with high potential of lymphatic metastatic Hca-F and its synogenetic cell line Hca-P with a low metastatic potential was constructed by suppression subtracted hybridization(SSH) method. The screened clones of the subtracted library were sequenced and GeneBank homology search was performed.RESULTS: Fourteen differentially expressed cDNA fragments of Hca-F were obtained with two novel genes.CONCLUSION: SSH is a useful technique to detect differentially expressioned genes and an effective method to clone novel genes. 展开更多
关键词 Suppression subtracted hybridization Liver neoplasm Lymphogenous metastasis
下载PDF
Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice 被引量:6
8
作者 Gui-Jun Zhao Li-Xia Xu +4 位作者 Eagle SH Chu Ning Zhang Jia-Yun Shen Alatangaole Damirin Xiao-Xing Li 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第47期7087-7092,共6页
AIM:To improve the outcome of orthotopic transplantation in a mouse model,we used an absorbable gelatin sponge(AGS) in nude mice to establish an orthotopic implantation tumor model.METHODS:MHCC-97L hepatocellular carc... AIM:To improve the outcome of orthotopic transplantation in a mouse model,we used an absorbable gelatin sponge(AGS) in nude mice to establish an orthotopic implantation tumor model.METHODS:MHCC-97L hepatocellular carcinoma(HCC)cells stably expressing the luciferase gene were injected into the subcutaneous region of nude mice.One week later,the ectopic tumors were harvested and transplanted into the left liver lobe of nude mice.The AGS was used to establish the nude mouse orthotopic implantation tumor model.The tumor suppressor gene,paired box gene 5(PAX5),which is a tumor suppressor in HCC,was transfected into HCC cells to validate the model.Tumor growth was measured by bioluminescence imaging technology.Semi-quantitative reverse transcription polymerase chain reaction(RT-PCR) and histopathology were used to confirm the tumorigenicity of the implanted tumor from the MHCC-97L cell line.RESULTS:We successfully developed an orthotopic transplantation tumor model in nude mice with the use of an AGS.The success rate of tumor transplantation was improved from 60% in the control group to 100% in the experimental group using AGS.The detection of fluorescent signals showed that tumors grew in all live nude mice.The mice were divided into 3 groups:AGS-,AGS+/PAX5-and AGS+/PAX5 +.Tumor size was significantly smaller in PAX5 transfected nude mice compared to control mice(P < 0.0001).These fluorescent signal results were consistent with observations made during surgery.Pathologic examination further confirmed that the tissues from the ectopic tumor were HCC.Results from RT-PCR proved that the HCC originated from MHCC-97L cells.CONCLUSION:Using an AGS is a convenient and efficient way of establishing an indirect orthotopic liver transplantation tumor model with a high success rate. 展开更多
关键词 Hepatocellular carcinoma Orthotopic transplantation tumor model Absorbable gelatin sponge Nude mice Bioluminescence imaging
下载PDF
Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects 被引量:2
9
作者 Ming-Rong Cheng Qing Li +8 位作者 Tao Wan Bing He Jiang Han Hou-Xiang Chen Feng-Xiao Yang Wei Wang Hong-Zhi Xu Tao Ye Bing-Bing Zha 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第42期6076-6087,共12页
AIM: To observe the curative effect of galactosylated chitosan (GC)/5-fluorouracil (5-FU) nanoparticles in liver caner mice and its side effects. METHODS: The GC/5-FU nanoparticle is a nanomate- rial made by cou... AIM: To observe the curative effect of galactosylated chitosan (GC)/5-fluorouracil (5-FU) nanoparticles in liver caner mice and its side effects. METHODS: The GC/5-FU nanoparticle is a nanomate- rial made by coupling GC and 5-FU. The release experiment was performed in vitro. The orthotropic liver cancer mouse models were established and divided into control, GC, 5-FU and GC/5-FU groups. Mice in the control and GC group received an intravenous injection of 200 μL saline and GC, respectively. Mice in the 5-FU and GC/5-FU groups received 200 μL (containing 0.371 mg 5-FU) 5-FU and GC/5-FU, respectively. The tumor weight and survival time were observed. The cell cycle and apoptosis in tumor tissues were monitored by flow cytometry. The expression of p53, Bax, Bcl-2, caspase-3 and poly adenosine 50-diphosphate-ribose polymerase 1 (PARP-1) was detected by immunohistochemistry, reverse transcription-polymerase chain reaction and Western blot. The serum blood biochemical parameters and cytotoxic activity of natural killer (NK) cell and cy- totoxicity T lymphocyte (CTL) were measured. RESULTS: The GC/5-FU nanoparticle is a sustained release system. The drug loading was 6.12% ± 1.36%, the encapsulation efficiency was 81.82% ± 5.32%, and the Zeta potential was 10.34 ± 1.43 mV. The tu- mor weight in the GC/5-FU group (0.4361±0.1153 g vs 1.5801 ± 0.2821 g, P 〈 0.001) and the 5-FU (0.7932±0.1283 g vs 1.5801 ±0.2821 g, P 〈 0.001) was sig- nificantly lower than that in the control group; GC/5- FU treatment can significantly lower the tumor weight (0.4361± 0.1153 g vs 0.7932±0.1283 g, P 〈 0.001), and the longest median survival time was seen in the GC/5-FU group, compared with the control (12 d vs 30 d, P 〈 0.001), GC (13 d vs 30 d, P 〈 0.001) and 5-FU groups (17 d vs 30 d, P 〈 0.001). Flow cytom- etry revealed that compared with the control, GC/5- FU caused a higher rate of G0-G1 arrest (52.79% ± 13.42% vs 23.92%±9.09%, P = 0.014 ) and apopto- sis (2.55% ±1.10% vs 11.13% ±11.73%, P 〈 0.001) in hepatic cancer cells. Analysis of the apoptosis path- ways showed that GC/5-FU upregulated the expression of p53 at both the protein and the mRNA levels, which in turn lowered the ratio of Bcl-2lBax expression; this led to the release of cytochrome C into the cytosol from the mitochondria and the subsequent activation of caspase-3. Upregulation of caspase-3 expression de- creased the PARP-1 at both the mRNA and the protein levels, which contributed to apoptosis. 5-FU increased the levels of aspartate aminotransferase and alanine aminotransferase, and decreased the numbers of platelet, white blood cell and lymphocyte and cytotoxic activities of CTL and NK cells, however, there were no such side effects in the GC/5-FU group. CONCLUSION: GC/5-FU nanoparticles can significant- ly inhibit the growth of liver cancer in mice via the p53 apoptosis pathway, and relieve the side effects and im- munosuppression of 5-FU. 展开更多
关键词 Galactosylated chitosan NANOPARTICLES 5-FLUOROURACIL Hepatocellular cancer Targeted thera-py Apoptosis
下载PDF
Pituitary transcriptome profile of liver cancer mice with different syndromes reveals the relevance of pituitary to the cancer and syndromes
10
作者 Xiaomei Liu Zhaoqin Fang +4 位作者 Zhiqiang Pan Wenli Lu Zhonghua Wu Chao Liang Yuanyuan Zhang 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2014年第6期691-698,共8页
OBJECTIVE: To investigate the relevance of the pituitary to liver syndromes and cancer by studying the pituitary transcriptome profile in liver cancer mice with different syndromes.METHODS: The quantitative four diagn... OBJECTIVE: To investigate the relevance of the pituitary to liver syndromes and cancer by studying the pituitary transcriptome profile in liver cancer mice with different syndromes.METHODS: The quantitative four diagnosis and syndrome differentiation methods were used to screen normal control mice without syndromes(NC), liver cancer mice with poisonous pathogenic factors syndrome(PPFS), and Qi deficiency syndrome mice(QDS). An Affymetrix Gene Chip MouseExon 1.0 ST Array was performed to detect the gene expression of different groups. Gene clustering was applied to analyze the gene expression patterns of the PPFS and QDS groups compared with the NC group. The transcriptional networks analysis tool, Fun Net, was used to enrich the biological categories of differentially expressed genes in the PPFS and QDS groups.RESULTS: Biological categories of differentially expressed genes showed that excessive metabolism and extracellular matrix interaction, insufficient communication of cells(especially nerve cells), and the bidirectional regulation of genetic information processing were enriched in both syndromes. However, the degree of excessive metabolism in the PPFS group was higher than that in the QDS group.The hyperfunction of cancer and infection, and the hypofunction of the nervous and endocrine systems were obvious in the QDS group.CONCLUSION: The pituitary plays an important role in the development of liver cancer and syndromes. This study further studied the role of the pituitary in the combination of disease and syndromes. 展开更多
关键词 Liver neoplasms Syndrome Pituitarygland TRANSCRIPTOME
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部